期刊文献+

依托咪酯静脉复合全麻对应激反应抑制作用的对比观察 被引量:2

下载PDF
导出
摘要 目的观察依托咪酯复合全麻对应激反应的抑制作用。方法择期腹腔镜胆囊切除术(LC)患者60例,年龄50~60岁,SASI-Ⅱ级,无呼吸、循环、内分泌系统疾病和烟酒嗜好患者,随机分成依托咪酯静脉复合全麻组(I组)和丙泊酚静脉复合全麻组(Ⅱ组),观察麻醉诱导前(T0)、麻醉诱导后(T1)、气管插管后5min(T2)、CO2气腹后5min(T3)和手术结束拔除气管导管后5min(T4)的心率(HR)、收缩压(SBP)、舒张压(DBP)血浆肾上腺素(E)、去甲肾上腺素(NE)、皮质醇(Cor)变化。结果 I组HR、SBP、DBP各时段变化差异无统计学意义(P>0.05),E、NE、Cor血浆浓度T1时较T0时降低(P<0.05),其他时段无变化差异无统计学意义(P>0.05);Ⅱ组T1时HR、SBP、DBP低于或慢于T0时(P<0.05),T3、T4时HR、SBP、DBP、E、NE、Cor均高于T0时(P<0.05);两组间比较,T3、T4时Ⅱ组的HR、SBP、DBP、E、NE、Cor均高于Ⅰ组(P<0.05)。结论依托咪酯静脉复合全麻对应激反应有较好的抑制作用。
作者 韩雨
出处 《中国实用医药》 2011年第24期182-183,共2页 China Practical Medicine
  • 相关文献

参考文献5

二级参考文献19

  • 1蒋奕红,黄龄瑾.靶控输注依托咪酯用于椎管内麻醉病人镇静的研究[J].广西医科大学学报,2004,21(5):711-712. 被引量:5
  • 2幸亨泰,梁万福,刘世倩.沙打旺有丝分裂染色体形态变化的观察[J].遗传,1995,17(4):35-36. 被引量:7
  • 3刘俊杰,现代麻醉学(第2版),1997年,293页
  • 4Lees N W,Br J Anaesth,1984年,56卷,1239页
  • 5王伟鹏,李立环,译.临床麻醉学[M].北京:人民卫生出版社,2004:977.
  • 6Singh S,Smith J E.Cardiovascular changes after the three stages of nasotracheal intubation[J].Br J Anaesth,2003,91(5):667 -671.
  • 7Iannuzzi E,Iannuzzi M,Cirillo V,,et al.Peri-intubation cardiovascular response during low dose remi-fentanil or sufentanil administration in association with propofol TCI[J].Minerva Anestesiol,2004,70(3):109-115.
  • 8Karki D B,Neopane A.A review on percutaneous coronary intervention vs.coronary artery bypass graft surgery[J].Kathmandu Univ Med J,2003,1 (4):284-287.
  • 9Mathieu N,Cnudde N,Engelman E,et al.Intranasal sufentanil is effective for postoperative analgesia in adults[J].Can J Anaesth,2006,53(1):60-66.
  • 10Lotsch J.Pharmacokinetic-pharmacodynamic modeling of opioids[J].J Pain Symptom Manage,2005,29 (5 Suppl):90-103.

共引文献32

同被引文献36

  • 1Alcock RF, Kouzios D, Naoum C,et al. Perioperative myocardial nec- rosis in patients at high cardiovascular risk undergoing elective non- cardiac surgery[ J ]. Heart,2012,98 ( 10 ) :792-798.
  • 2Miler Petrun A, Kamenik M. Bispectral index-guided induction of general anaesthesia in patients undergoing major abdominal surgery using propofol or etomidate : a double-blind, randomized, clinical tri- al[J]. Br J Anaesth,2013,110(3) :388-396.
  • 3Mandt M J, Roback MG, Bajaj L, et al. Etomidate for short pediatric procedures in the emergency department [ J ]. Pediatr Emerg Care, 2012,28(9) :898-904.
  • 4Mettauer N, Brierley J. A novel use of etomidate for intentional adre- nal suppression to control severe hypercortisolemia in childhood[ J]. Pediatr Crit Care Med ,2009,10(3 ) :37-40.
  • 5Hoyer C, Kranaster L, Janke C ,et al. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy : a retrospective study [ J]. Enr Arch Psychiatry Clin Neurosc1,2014,264( 3 ) :255-261.
  • 6Sunshine J, Deem S, Weiss N, et al. Etomidate, Adrenal Function and Mortality in Critically m Patients [ J]. Respir Care, 2013,58 (4) :639-646.
  • 7Brock MF, Grace BE, Morley B,et al. Does lidocaine more effectively prevent pain upon induction with propofol oretomidate when givenpreemptively than when mixed with the drug [ J ] ? J Clin Anesth, 2010,22 ( 7 ) :505-509.
  • 8Gu|top F,Akkaya T,Bedirli N,et al. Lidocaine pretreatment reduces the frequency and severity of myoclonus induced by etomidate[ J ]. J Anesth,2010,24(2) :300-302.
  • 9Un B, Ceyhan D, Yelken B. Prevention of etomidate-related myoclo- nus in anesthetic induction by pretreatment with magnesium [ J ]. J Res Med Sci,2011,16(11) :1490-1494.
  • 10Cotten JF, Forman SA, Laha JK, et al. Carboetomidate : A pyrrole ana- log of etomidate designed not to suppress adrenocortical function [ J ]. Anesthesiology ,2010,112 ( 3 ) :637-644.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部